Drug Information
Interaction between the Drug and Microbe | Top | |||
---|---|---|---|---|
The Metabolism of Drug Affected by Studied Microbe(s) | ||||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Bacteroidales | ||||
Studied Microbe: Bacteroides uniformis ATCC 8492
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Bacteroides uniformis ATCC 8492 (log2FC = -1.698; p = 0.036). | |||
Studied Microbe: Parabacteroides distasonis ATCC 8503
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Parabacteroides distasonis ATCC 8503 (log2FC = -0.69; p = 0.018). | |||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Enterobacterales | ||||
Studied Microbe: Escherichia coli BW25113
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Escherichia coli BW25113 (log2FC = -0.477; p = 0.011). | |||
Studied Microbe: Salmonella typhimurium LT2
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Salmonella typhimurium LT2 (log2FC = -0.567; p = 0.042). | |||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Eubacteriales | ||||
Studied Microbe: Blautia hansenii DSM20583
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Blautia hansenii DSM20583 (log2FC = -0.433; p = 0.034). | |||
Studied Microbe: Clostridium difficile 120
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Clostridium difficile 120 (log2FC = -2.744; p = 0.007). | |||
Studied Microbe: Clostridium sp.
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Experimental Method | High-throughput screening | |||
Description | Nicergoline can be metabolized by Clostridium sp. (log2FC = -0.482; p = 0.041). |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor Alpha-2 (ADRA2) | Target Info | Antagonist | [4], [5] |
References | Top | |||
---|---|---|---|---|
REF 1 | Drug information of Nicergoline, 2008. eduDrugs. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 3 | Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019 Jun;570(7762):462-467. | |||
REF 4 | Effect of non-selective alpha-adrenergic receptor antagonist nicergoline on the activity of neurons in the ventral lateral thalamic nucleus. Fiziol Zh. 2005;51(4):29-35. | |||
REF 5 | Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology (Berl). 1995 Feb;117(4):385-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.